Schomburg Lutz, Dumitrescu Alexandra M, Liao Xiao-Hui, Bin-Abbas Bassam, Hoeflich Johanna, Köhrle Josef, Refetoff Samuel
Institute for Experimental Endocrinology, Charité-University Medicine Berlin, Berlin, Germany.
Thyroid. 2009 Mar;19(3):277-81. doi: 10.1089/thy.2008.0397.
Selenium (Se) is an essential trace element needed for the biosynthesis of selenoproteins. Selenocysteine incorporation sequence binding protein 2 (SBP2) represents a key trans-acting factor for the co-translational insertion of selenocysteine into selenoproteins. We recently described children with mutations in the SBP2 gene who displayed abnormal thyroid function tests and reduced selenoprotein concentrations. We have tried to improve selenoprotein biosynthesis and thyroid hormone metabolism in SBP2 deficient subjects by supplementing an organic and an inorganic Se form.
Three affected and two unaffected siblings received daily doses of 100, 200, or 400 microg selenomethionine-rich yeast and 400 microg sodium selenite for one month each. Serum was drawn at baseline and after supplementations. Thyroid function tests, extracellular glutathione peroxidase activity, Se, and selenoprotein P concentrations were determined.
Selenomethionine-rich yeast increased serum Se concentrations in all subjects irrespective of genotype. Sodium selenite was effective in increasing the selenoprotein P concentration in normal and to a lesser degree in affected subjects. Both forms failed to increase the glutathione peroxidase activity or to correct the thyroid function abnormalities in the SBP2 deficient individuals indicating that impaired deiodinase expression was not positively affected. No adverse side effects were observed.
Total serum Se concentrations in SBP2 deficient subjects respond to selenomethionine supplementation but this effect is not indicative for improved selenoprotein synthesis. Se is obviously not a limiting factor in the SBP2 deficient individuals when regular daily Se intake is provided. These findings might help to identify and diagnose more individuals with selenoprotein biosynthesis defects who might present at young age irrespective of their Se supply with characteristic thyroid function test abnormalities, growth retardation, and reduced Se and selenoprotein concentrations.
硒(Se)是硒蛋白生物合成所需的必需微量元素。硒代半胱氨酸插入序列结合蛋白2(SBP2)是硒代半胱氨酸共翻译插入硒蛋白过程中的关键反式作用因子。我们最近描述了SBP2基因发生突变的儿童,他们的甲状腺功能测试异常,硒蛋白浓度降低。我们试图通过补充有机和无机硒形式来改善SBP2缺乏受试者的硒蛋白生物合成和甲状腺激素代谢。
三名受影响和两名未受影响的兄弟姐妹分别每天服用100、200或400微克富含硒代蛋氨酸的酵母和400微克亚硒酸钠,各服用一个月。在基线时和补充后采集血清。测定甲状腺功能测试、细胞外谷胱甘肽过氧化物酶活性、硒和硒蛋白P浓度。
无论基因型如何,富含硒代蛋氨酸的酵母均能提高所有受试者的血清硒浓度。亚硒酸钠可有效提高正常受试者的硒蛋白P浓度,对受影响受试者的提高程度较小。两种形式均未能提高SBP2缺乏个体的谷胱甘肽过氧化物酶活性或纠正甲状腺功能异常,这表明脱碘酶表达受损未得到积极改善。未观察到不良副作用。
SBP2缺乏受试者的总血清硒浓度对补充硒代蛋氨酸有反应,但这种作用并不表明硒蛋白合成得到改善。当提供常规每日硒摄入量时,硒显然不是SBP2缺乏个体的限制因素。这些发现可能有助于识别和诊断更多硒蛋白生物合成缺陷的个体,这些个体可能在年轻时出现,无论其硒供应情况如何,都具有特征性的甲状腺功能测试异常、生长发育迟缓以及硒和硒蛋白浓度降低。